Avalo Therapeutics Inc (AVTX): Good morning! $AVTX

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	131
Posts	3641
Boards Moderated	6
Alias Born	07/04/2019

INV4

Re: None

Tuesday, 09/26/2023 4:05:27 AM

Tuesday, September 26, 2023 4:05:27 AM

Good morning!
$AVTX

Don't invest what you can't afford to lose. Always do your own DD. INV4$

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AVTX News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/12/2026 10:09:39 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:20:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:18:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:16:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:15:10 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:54:16 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:32:13 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:30:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:29:41 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/06/2026 03:00:55 PM
Avalo Therapeutics Announces Pricing of $375 Million Public Offering • GlobeNewswire Inc. • 05/06/2026 03:33:54 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/05/2026 08:28:31 PM
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:01:30 PM
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:37:50 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/29/2026 08:33:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:01:21 AM
Avalo Therapeutics Purchases Optional Milestone Buyout • GlobeNewswire Inc. • 04/28/2026 11:00:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:02:49 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:01:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:51:43 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:34:20 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent AVTX News

More AVTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent AVTX News

Go Ad-Free